Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

Celgene Corporation (CELG)

-NasdaqGS
141.51 0.35(0.25%) Apr 17, 4:00PM EDT
|Pre-Market : 142.00 Up 0.49 (0.35%) 8:21AM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:141.86
Open:141.98
Bid:142.00 x 300
Ask:142.49 x 100
1y Target Est:193.21
Beta:1.08
Next Earnings Date:24-Apr-14CELG Earnings announcement
Day's Range:140.29 - 144.07
52wk Range:110.53 - 174.66
Volume:2,977,306
Avg Vol (3m):3,911,880
Market Cap:57.46B
P/E (ttm):41.99
EPS (ttm):3.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 0.25%57.46B
JNJ279.95B

Key Statistics

Forward P/E (1 yr):14.77
P/S (ttm):8.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :7.28
Quarterly EPS Est (Mar-14) :1.65
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.77

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback